Julia Talajic

Julia Talajic serves as a Clinical Associate Professor in the Department of Ophthalmology at the University of Montreal's Faculty of Medicine. She maintains clinical and research affiliations with the Réseau de recherche en santé de la vision (RRSV) and the CIUSSS de l'Est-de-l'Île-de-Montréal – Hôpital Maisonneuve-Rosemont (HMR). Her academic profile reflects a specialized focus on corneal transplantation techniques and visual system disorders, with particular emphasis on innovative surgical approaches.

Dr. Talajic's research interests center on corneal transplantation, specifically Descemet's Membrane Endothelial Keratoplasty (DMEK), where she pioneered Canada's first 3D microscope-assisted corneal graft procedure in the fall of 2015. Her expertise spans transplant rejection mechanisms, anterior segment surgery innovations, and managing complex corneal diseases. She has made significant contributions to understanding DMEK graft preparation techniques, intraoperative complications, and novel instrumentation for endothelial keratoplasty.

Analysis of her publication record from 2013-2024 reveals a consistent trajectory of innovation in corneal surgery. Her work demonstrates progression from foundational DSAEK techniques to advanced DMEK applications, with recent publications addressing emerging challenges such as post-vaccination ocular surface disorders and optimizing surgical materials for endothelial cell preservation. The research shows increasing sophistication in graft preparation methods and complication management.

Dr. Talajic maintains active clinical practice at Hôpital Maisonneuve-Rosemont where she applies her research innovations directly to patient care. Her work bridges the gap between laboratory research and clinical application, particularly in advancing corneal transplantation techniques for complex cases including aniridia patients requiring keratoprosthesis.